TOVX Theriva Biologics
- 0.3060
- -0.0250-7.55%
- 0.2900
- -0.0160-5.23%
Theriva Biologics News
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Officer SHALLCROSS STEVEN A
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director Wolf Jeffrey Alan
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director Kraws Jeffrey J
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director MONAHAN JOHN J
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Officer SHALLCROSS STEVEN A
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Officer SHALLCROSS STEVEN A
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Theriva Biologics | 4: Statement of changes in beneficial ownership of securities
Synthetic Biologics | D: Filing D
Synthetic Biologics | 3: Initial statement of beneficial ownership of securities-Chief Operating Officer Tufaro Francis
Synthetic Biologics | D: Filing D
Synthetic Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Abbe(1.92%),Iroquois Capital Management L.L.C.(0.89%), etc.
Analysis
Price Target
No Data
